- Home
-
Learn, develop, connect
8th Global QA Conference
Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information -
Membership
Become part of RQA today
RQA membership is a great way to connect with your QA colleagues.
More information
RQA Community Hub
Join the community - networking, discussion and more. Open to all.
More information -
Knowledge Hub
Contribute to Quasar Magazine
Could you write an interesting article for the RQA community?
More information - About us
News Archive
EMA issues new guidance on conducting clinical trials during public health emergencies in the EU
12th March 2026The European Medicines Agency has released new guidance to support clinical trials during public health emergencies.
FDA launches new Adverse Event Look-up Tool
12th March 2026The US Food and Drug Administration has introduced a new tool to improve access to adverse event data.
FDA publishes CDER Guidance Agenda outlining planned drug guidance documents
12th March 2026The US Food and Drug Administration has published its latest CDER Guidance Agenda setting out potential guidance documents for drug regulation.
MHRA News: £14bn opportunity identified through medicine reclassification
12th March 2026New analysis highlights the economic and healthcare benefits of expanding access to medicines through reclassification.
Singapore reaches WHO’s highest classification for medical device regulation
12th March 2026Singapore has become the first country to achieve the World Health Organization’s highest classification for medical device regulatory systems.
Global impact of UK health data resource highlighted in newly published paper
11th March 2026A new paper highlights the worldwide research impact of a major UK health data resource.
IMDRF launches consultation on clinical evidence for IVD medical devices
11th March 2026The International Medical Device Regulators Forum has opened a public consultation on new guidance for clinical evidence and performance evaluation of IVD medical devices.
MHRA publishes guidance on GMP and radiopharmaceutical investigational medicines in clinical trials
11th March 2026New UK guidance explains manufacturing and regulatory expectations for investigational medicines used in clinical trials.
Human Medicines Highlights March 2026
6th March 2026The newsletter for patients, consumers and healthcare professionals
E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports
5th March 2026The FDA has published draft guidance based on the ICH E2D(R1) guideline, which updates international standards for managing and reporting post-approval safety data for medicines.
- Home
- Learn, develop, connect
- Membership
- Knowledge Hub
- About us